461
Participants
Start Date
November 5, 2019
Primary Completion Date
July 26, 2023
Study Completion Date
July 30, 2027
Nivolumab
Specified dose on specified days
Carboplatin
Specified dose on specified days
Cisplatin
Specified dose on specified days
Paclitaxel
Specified dose on specified days
Pemetrexed
Specified dose on specified days
Placebo
Specified dose on specified days
Docetaxel
Specified dose on specified days
Local Institution - 0116, New Taipei City
Local Institution - 0149, Kaohsiung City
Local Institution - 0119, Kaohsiung City
Local Institution - 0030, CABA
Local Institution - 0032, Ciudad Autonoma Beunos Aires
Local Institution - 0020, Sydney
Local Institution - 0002, Edegem
Local Institution - 0122, Melbourne
Local Institution - 0033, Heidelberg
Local Institution - 0005, Liège
Local Institution - 0001, Roeselare
Local Institution - 0085, Berlin
Local Institution - 0026, Milan
Rcca Md Llc, Bethesda
Local Institution - 0103, Fredericksburg
Local Institution - 0063, Lübeck
Local Institution - 0073, Besançon
Local Institution - 0046, Madrid
Local Institution - 0044, Majadahonda - Madrid
Local Institution - 0040, Atlanta
Local Institution - 0120, Augusta
Local Institution - 0028, Chihuahua City
Local Institution - 0023, North Ballarat
Local Institution - 0104, Tampa
Local Institution - 0050, Montpellier
Local Institution - 0083, Rennes
Local Institution - 0037, La Tronche
Local Institution - 0025, Parma
Local Institution - 0102, Cleveland
Local Institution - 0077, Guadalajara
Local Institution - 0055, Cincinnati
Local Institution - 0045, Valencia
Local Institution - 0024, Forlì
Local Institution - 0070, Moers
Local Institution - 0072, Georgsmarienhütte
Local Institution - 0086, Traverse City
Local Institution - 0110, Cologne
Local Institution - 0071, Hamm
Local Institution - 0121, Orland Park
Local Institution - 0065, Frankfurt
Local Institution - 0145, Chicago
Local Institution - 0078, Chicago
Local Institution - 0027, Monterrey
Local Institution - 0108, Heidelberg
Local Institution - 0147, Ludwigsburg
Local Institution - 0064, Löwenstein
Local Institution - 0038, Paris
Local Institution - 0051, Paris
Local Institution - 0146, Rouen
Local Institution - 0054, Houston
Local Institution - 0066, München
Local Institution - 0109, Immenstadt im Allgäu
Local Institution - 0115, Beijing
Local Institution - 0096, Beijing
Local Institution - 0112, Taipei
Local Institution, Moscow
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution - 0098, Shanghai
Local Institution - 0165, Shanghai
Local Institution - 0095, Shanghai
Local Institution - 0113, Shanghai
Local Institution - 0099, Hangzhou
Local Institution - 0137, Fuzhou
Local Institution - 0136, Fuzhou
Local Institution - 0013, Cluj-Napoca
Local Institution - 0012, Floreşti
Local Institution - 0092, Changsha
Local Institution - 0093, Changsha
Local Institution - 0091, Changsha
Local Institution - 0151, Hubei Sheng
Local Institution - 0088, Chengdu
Local Institution - 0143, Chuo-ku
Local Institution - 0142, Bunkyo-ku
Local Institution - 0133, Bunkyo-ku
Local Institution - 0124, Kashiwa-shi
Local Institution - 0130, Kitaadachigun
Local Institution - 0135, Nagoya
Local Institution - 0134, Chuo-ku
Local Institution - 0126, Sakai-shi
Local Institution - 0127, Kobe
Local Institution - 0129, Kitakyushu-shi
Local Institution - 0144, Kanazawa
Local Institution - 0131, Sendai
Local Institution - 0076, Boston
Local Institution - 0074, Newton
Local Institution - 0100, Lebanon
Local Institution - 0031, ABB
Local Institution - 0043, Buenos Aires
Local Institution - 0035, Belo Horizonte
Local Institution - 0029, Ijuí
Local Institution - 0036, São Paulo
Local Institution - 0034, São Paulo
Local Institution - 0106, São Paulo
Local Institution - 0062, Oshawa
Local Institution - 0041, Prague
Local Institution - 0042, Prague
Local Institution - 0016, Dublin
Local Institution - 0125, Yokohama
Local Institution - 0132, Fukushima
Local Institution - 0128, Hiroshima
Local Institution - 0004, Groningen
Local Institution - 0003, Rotterdam
Local Institution - 0049, Krakow
Local Institution - 0117, Hato Rey
Local Institution - 0011, Bucharest
Local Institution - 0007, Taunton
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY